Pegulicianine: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Pegulicianine. Educational only — not medical advice.

Labeled uses

LUMISIGHT is indicated for fluorescence imaging in adults with breast cancer as an adjunct for the intraoperative detection of cancerous tissue within the resection cavity following removal of the primary specimen during lumpectomy surgery.

Source: FDA labeling via NIH DailyMed (set 7160e774…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.